A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours
详细信息 查看全文
- 作者：Juan Martínez-Aguilar ; Roderick Clifton-Bligh ; Mark P Molloy
- 关键词：S100 proteins ; Selected reaction monitoring ; Mass spectrometry ; Thyroid cancer ; Tumour tissue samples
- 刊名：BMC Cancer
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：15
- 期：1
- 全文大小：1,506 KB
- 参考文献：1. Salama, I, Malone, PS, Mihaimeed, F, Jones, JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34: pp. 357-64 CrossRef
2. Chen, H, Xu, C, Jin, Q, Liu, Z (2014) S100 protein family in human cancer. Am J Cancer Res 4: pp. 89-115
3. Gross, SR, Sin, CG, Barraclough, R, Rudland, PS (2014) Joining S100 proteins and migration: for better or for worse, in sickness and in health. Cell Mol Life Sci 71: pp. 1551-79 CrossRef
4. Marenholz, I, Heizmann, CW, Fritz, G (2004) S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322: pp. 1111-22 CrossRef
5. Sedaghat, F, Notopoulos, A (2008) S100 protein family and its application in clinical practice. Hippokratia 12: pp. 198-204
6. Huang, L, Xu, Y, Cai, G, Guan, Z, Sheng, W, Lu, H (2011) S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer. World J of Gastroenterol 17: pp. 69-78 CrossRef
7. Rudland, PS, Platt-Higgins, A, Renshaw, C, West, CR, Winstanley, JH, Robertson, L (2000) Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: pp. 1595-603
8. Wang, YY, Ye, ZY, Zhao, ZS, Tao, HQ, Chu, YQ (2010) High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann Surg Oncol 17: pp. 89-97 CrossRef
9. Tsukamoto, N, Egawa, S, Akada, M, Abe, K, Saiki, Y, Kaneko, N (2013) The expression of S100A4 in human pancreatic cancer is associated with invasion. Pancreas 42: pp. 1027-33 CrossRef
10. Saleem, M, Kweon, MH, Johnson, JJ, Adhami, VM, Elcheva, I, Khan, N (2006) S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci U S A 103: pp. 14825-30 CrossRef
11. Cross, SS, Hamdy, FC, Deloulme, JC, Rehman, I (2005) Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46: pp. 256-69 CrossRef
12. Komatsu, K, Andoh, A, Ishiguro, S, Suzuki, N, Hunai, H, Kobune-Fujiwara, Y (2000) Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin Cancer Res 6: pp. 172-7
13. Yang, YQ, Zhang, LJ, Dong, H, Jiang, CL, Zhu, ZG, Wu, JX (2007) Upregulated expression of S100A6 in human gastric cancer. J Dig Dis. 8: pp. 186-93 CrossRef
14. Ohuchida, K, Mizumoto, K, Yu, J, Yamaguchi, H, Konomi, H, Nagai, E (2007) S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples. Cancer Epidemiol Biomarkers Prev 16: pp. 649-54 CrossRef
15. Rehman, I, Cross, SS, Azzouzi, AR, Catto, JW, Deloulme, JC, Larre, S (2004) S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br J Cancer 91: pp. 739-44
16. Arai, K, Takano, S, Teratani, T, Ito, Y, Yamada, T, Nozawa, R (2008) S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr Cancer Drug Targets 8: pp. 243-52 CrossRef
17. Duan, L, Wu, R, Ye, L, Wang, H, Yang, X, Zhang, Y (2013) S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/beta-catenin pathway. PLoS One 8: pp. e62092
文摘
Background Mounting evidence demonstrates a causal role for S100 proteins in tumourigenesis and several S100 isoforms have shown utility as biomarkers of several types of cancer. The S100 family is comprised of 21 small isoforms, many of them implicated in important cellular functions such as proliferation, motility and survival. Furthermore, in vivo experiments have proven the role of S100 proteins in tumour growth and disease progression, while other studies have shown their prognostic value and involvement in resistance to chemotherapy drugs. Taken together, all these aspects highlight S100 proteins as potential therapeutic targets and as a promising panel of cancer biomarkers. In this work, we have developed a mass spectrometry (MS)-based method for the multiplexed and specific analysis of the entire S100 protein family in tumour tissues and have applied it to investigate the expression of S100 isoforms in the context of thyroid cancer, the main endocrine malignancy. Methods Selected Reaction Monitoring (SRM)-MS and stable isotope labelling/label-free analysis were employed to investigate the expression of the 21?S100 protein isoforms in thyroid tissue samples. Specimens included 9 normal thyroid tissues and 27 tumour tissues consisting of 9 follicular adenomas (FA), 8 follicular carcinomas (FTC) and 10 papillary carcinomas (PTC). Results The multiplexed and targeted mass spectrometry method led to the detection of eleven S100 protein isoforms across all tissues. Label- and label-free analyses showed the same significant differences and results were confirmed by western blot. S100A6, S100A11 and its putative interaction partner annexin A1 showed the highest overexpression in PTC compared to normal thyroid. S100A13 was also elevated in PTC. Reduced S100A4 expression was observed in FA compared to all other tissues. FA and FTC showed reduction of S100A10 and annexin A2 expression. Conclusions Targeted mass spectrometry allows the multiplexed and specific analysis of S100 protein isoforms in tumour tissue specimens. It revealed S100A13 as a novel candidate PTC biomarker. Results show that S100A6, S100A11 and Annexin A1 could help discriminate follicular and papillary tumours. The diagnostic and functional significance of S100A4 and S100A10 reduction in follicular tumours requires further investigation.